Protective and destructive innate immune responses to enteropathogenic Escherichia coli and related A/E pathogens

Future Microbiology

Volumn 3, Issue 3, 2008, Pages 315-328

  Lebeis, Sarah L ^a   Sherman, Melanie A ^a   Kalman, Daniel ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Citrobacter rodentium; Colitis; EHEC; EPEC; Innate immunity; Toll like receptor

Indexed keywords

FLAGELLIN; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 2; MONOCYTE CHEMOTACTIC PROTEIN 1; MYELOID DIFFERENTIATION FACTOR 88; POLYPEPTIDE ANTIBIOTIC AGENT; STAT1 PROTEIN; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; VIRULENCE FACTOR;

ACUTE DIARRHEA; ANTIBACTERIAL ACTIVITY; ANTIBODY RESPONSE; ANTIGEN PRESENTING CELL; ANTIINFLAMMATORY ACTIVITY; BACTERICIDAL ACTIVITY; BACTERIUM ADHERENCE; CELL TYPE; CITROBACTER RODENTIUM; CYTOKINE PRODUCTION; DENDRITIC CELL; ENTERITIS; ENTEROHEMORRHAGIC ESCHERICHIA COLI; ENTEROPATHOGENIC ESCHERICHIA COLI; GRAM NEGATIVE INFECTION; HUMAN; IMMUNOSTIMULATION; IN VITRO STUDY; IN VIVO STUDY; INNATE IMMUNITY; INTESTINE EPITHELIUM; INTESTINE FLORA; MACROPHAGE; MAST CELL; MICROVILLUS; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; REVIEW; TISSUE REPAIR; ANIMAL; ENTEROBACTER INFECTION; IMMUNOLOGY; PATHOLOGY;

BACTERIA (MICROORGANISMS); CITROBACTER RODENTIUM; ESCHERICHIA COLI;

ANIMALS; CITROBACTER RODENTIUM; ENTEROBACTERIACEAE INFECTIONS; ENTEROHEMORRHAGIC ESCHERICHIA COLI; ENTEROPATHOGENIC ESCHERICHIA COLI; HUMANS; IMMUNITY, NATURAL;

EID: 46049118081     PISSN: 17460913     EISSN: None     Source Type: Journal    
DOI: 10.2217/17460913.3.3.315     Document Type: Review

References (101)

1. Frankel G, Phillips AD, Rosenshine I, Dougan G, Kaper JB, Knutton S: Enteropathogenic and enterohaemorrhagic Escherichia coli. more subversive elements. Mol. Microbiol. 30, 911-921 (1998).
2. Mead PS, Slutsker L, Dietz V et al.: Food-related illness and death in the United States. Emerg. Infect. Dis. 5, 607-625 (1999).
3. Karch H, Tarr PI, Bielaszewska M: Enterohaemorrhagic Escherichia coli in human medicine. Int J Med. Microbiol. 295, 405-418 (2005).
4. Noel JM, Boedeker EC: Enterohemorrhagic Escherichia coli. a family of emerging pathogens. Dig. Dis. 15, 67-91 (1997).
5. McDaniel TK, Jarvis KG, Donnenberg MS, Kaper JB: A genetic locus of enterocyte effacement conserved among diverse enterobacterial pathogens. Proc. Natl Acad. Sci. USA 92, 1664-1668 (1995).
6. Deng W, Puente JL, Gruenheid S et al.: Dissecting virulence: systematic and functional analyses of a pathogenicity island. Proc. Natl Acad. Sd. USA 101, 3597-3602 (2004).
7. Klapproth JM, Sasaki M, Sherman M et al.: Citrobacter rodentium lifA/efa1 is essential for colonic colonization and crypt cell hyperplasia in vivo. Infect. Immun. 73, 1441-1451 (2005).
8. Lupp C, Robertson ML, Wickham ME et al.: Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae. Cell Host Microbe 2, 119-129 (2007).
9. Luperchio SA, Schauer DB: Molecular pathogenesis of Citrobacter rodentium and transmissible murine colonic hyperplasia. Microbes Infect. 3, 333-340 (2001).
10. Donnenberg MS: Enteropathogenic Escherichia coli. In: Infections of the Gastrointestinal Tract. Blaser M et al. (Eds). Lippincott Williams & Wilkins, Philadelphia, USA 595-612 (2002).
11. Higgins LM, Frankel G, Douce G, Dougan G, MacDonald TT: Citrobacter rodentium infection in mice elicits a mucosal Th1 cytokine response and lesions similar to those in murine inflammatory bowel disease. Infect. Immun. 67, 3031-3039 (1999).
12. Westerholt S, Pieper AK, Griebel M, Volk HD, Hartung T, Oberhoffer R: Characterization of the cytokine immune response in children who have experienced an episode of typical hemolytic-uremic syndrome. Clin. Diagn. Lab. Immunol. 10, 1090-1095 (2003).
13. Hemmi H, Takeuchi O, Kawai T et al.: A Toll-like receptor recognizes bacterial DNA. Nature 408, 740-745 (2000).
14. Kaisho T, Akira S: Pleiotropic function of Toll-like receptors. Microbes Infect. 6, 1388-1394 (2004).
15. Niess JH, Reinecker HC: Dendritic cells in the recognition of intestinal microbiota. Cell. Microbiol. 8, 558-564 (2006).
16. Niess JH, Reinecker HC: Lamina propria dendritic cells in the physiology and pathology of the gastrointestinal tract. Curr. Opin. Gastroenterol. 21, 687-691 (2005).
17. Maaser C, Housley MP, Iimura M et al.: Clearance of Citrobacter rodentium requires B cells but not secretory immunoglobulin A (IgA) or IgM antibodies. Infect. Immun. 72, 3315-3324 (2004).
18. Donnenberg MS, Tacket CO, Losonsky G et al.: Effect of prior experimental human enteropathogenic Escherichia coli infection on illness following homologous and heterologous rechallenge. Infect. Immun. 66, 52-58 (1998).
19. Bommarius B, Maxwell D, Swimm A et al.: Enteropathogenic Escherichia coli Tir is an SH2/3 ligand that recruits and activates tyrosine kinases required for pedestal formation. Mol. Microbiol. 63, 1748-1768 (2007).
20. Campellone KG, Robbins D, Leong JM. EspFU is a translocated EHEC effector that interacts with Tir and N-WASP and promotes Nck-independent actin assembly. Dev. Cell 7, 217-228 (2004).
21. Swimm AI, Kalman D: Cytosolic extract induces Tir translocation and pedestals in PEC-infected red blood cells. PLoS Pathog. 4, e4 (2008).
22. Canil C, Rosenshine I, Ruschkowski S, Donnenberg MS, Kaper JB, Finlay BB: Enteropathogenic Esherichia coli decreases the transepithelial electrical resistance of polarized epithelial monolayers. Infect. Immun. 61, 2755-2762 (1993).
23. Stein MA, Mathers DA, Yan H, Baimbridge KG, Finlay BB: Enteropathogenic Escherichia coli markedly decreases the resting membrane potential of Caco-2 and HeLa human epithelial cells. Infect. Immun. 64, 4820-4825 (1996).
24. Savkovic SD, Koutsouris A, Hecht G: Activation of NF-κB in intestinal epithelial cells by enteropathogenic Echerichia coli. Am. J. Physiol. 273, C1160-C1167 (1997).
25. Zhou X, Giron JA, Torres AG et al.: Flagellin of enteropathogenic Escherichia coli stimulates interleukin-8 production in T84 cells. Infect. Immun. 71, 2120-2129 (2003).
26. Khan MA, Bouzari S, Ma C et al.: Flagellin-dependent and -independent inflammatory responses following infection by enteropathogenic Escherichia coli (EPEC) and Citrobacter rodentium. Infect. Immun. 76(4), 1410-1422 (2008).
27. Ruchaud-Sparagano MH, Maresca M, Kenny B: Enteropathogenic Escherichia coli (EPEC) inactivate innate immune responses prior to compromising epithelial barrier function. Cell. Microbiol. 9, 1909-1921 (2007).
28. Jandu N, Ceponis PJ, Kato S, Riff JD, McKay DM, Sherman PM: Conditioned medium from enterohemorrhagic Escherichia coli-infected T84 cells inhibits signal transducer and activator of transcription 1 activation by γ interferon. Infect. Immun. 74, 1809-1818 (2006).
29. Lathem WW, Bergsbaken T, Witowksi SE, Perna NT, Welch RA: Acquisition of stcE, a C1 esterase inhibitor-specific metalloprotease, during the evolution of Escherichia coli O157:H7. J. Infect. Dis. 187, 1907-1914 (2003).
30. DeVinney R, Gauthier A, Abe A, Finlay BB: Enteropathogenic Escherichia coli. a pathogen that inserts its own receptor into host cells. Cell. Mol. Life Sci. 55, 961-976 (1999).
31. Ramirez K, Huerta R, Oswald E, Garcia-Tovar C, Hernandez JM, Navarro-Garcia F: Role of EspA and intimin in expression of proinflammatory cytokines from enterocytes and lymphocytes by rabbit enteropathogenic Escherichia coli-infected rabbits. Infect. Immun. 73, 103-113 (2005).
32. Inman LR, Cantey JR: Specific adherence of Esherichia coli (strain RDEC-1) to membranous (M)-cells of the Peyer's patch in Ekscherichia coli diarrhea in the rabbit. J. Clin. Invest. 71, 1-8 (1983).
33. Tzipori S, Gibson R, Montanaro J: Nature and distribution of mucosal lesions associated with enteropathogenic and enterohemorrhagic Escherichia coli in piglets and the role of plasmid-mediated factors. Infect. Immun. 57, 1142-1150 (1989).
34. Donnenberg MS, Tacket CO, James SP et al.: Role of the eaeA gene in experimental enteropathogenic Escherichia coli infection. J. Clin. Invest. 92, 1412-1417 (1993).
35. Campellone KG, Roe AJ, Lobner-Olesen A et al.: Increased adherence and actin pedestal formation by dam-deficient enterohaemorrhagic Escherichia coliO157:H7. Mol. Microbiol. 63, 1468-1481 (2007).
36. Savkovic SD, Villanueva J, Turner JR, Matkowskyj KA, Hecht G: Mouse model of enteropathogenic Escherichia coli infection. Infect. Immun. 73, 1161-1170 (2005).
37. Mundy R, Girard F, FitzGerald AJ, Frankel G: Comparison of colonization dynamics and pathology of mice infected with enteropathogenic Escherichia coli, enterohaemorrhagic E. coli and Citrobacter rodentium. FEMS Microbiol. Lett. 265, 126-132 (2006).
38. Taguchi H, Takahashi M, Yamaguchi H et al.: Experimental infection of germ-free mice with hyper-toxigenic enterohaemorrhagic Escherichia coli 0157:H7, strain 6. J. Med. Microbiol. 51, 336-343 (2002).
39. Alba Y, Ishikawa H, Shimizu K et al.: Role of internalization in the pathogenicity of Shiga toxin-producing Escherichia coli infection in a gnotobiotic murine model. Microbiol. Immunol. 46, 723-731 (2002).
40. Chong Y, Fitzhenry R, Heuschkel R, Torrente F, Frankel G, Phillips AD: Human intestinal tissue tropism in Escherichia coli O157: H7-initial colonization of terminal ileum and Peyer's patches and minimal colonic adhesion ex vivo. Microbiology 153, 794-802 (2007).
41. Miyamoto Y, Iimura M, Kaper JB, Torres AG, Kagnoff MF: Role of Shiga toxin versus H7 flagellin in enterohaemorrhagic Escherichia coli signalling of human colon epithelium in vivo. Cell. Microbiol. 8, 869-879 (2006).
42. Gewirtz AT, Navas TA, Lyons S, Godowski PJ, Madara JL: Cutting edge: bacterial flagellin activates basolaterally expressed TLR5 to induce epithelial proinflammatory gene expression. J. Immunol. 167, 1882-1885 (2001).
43. McCune JM: Development and applications of the SCID-hu mouse model. Semin. Immunol. 8, 187-196 (1996).
44. Borenshtein D, McBee ME, Schauer DB: Utility of the Citrobacter rodentium infection model in laboratory mice. Curr. Opin. Gastroenterol. 24, 32-37 (2008).
45. Schauer DB, Falkow S: The eae gene of Citrobacter freundii biotype 4280 is necessary for colonization in transmissible murine colonic hyperplasia. Infect. Immun. 61, 4654-4661 (1993).
46. Luperchio SA, Schauer DB: Molecular pathogenesis of Citrobacter rodentium and transmissible murine colonic hyperplasia. Microbes Infect. 3, 333-340 (2001).
47. Kelly M, Hart E, Mundy R et al.: Essential role of the type III secretion system effector N1eB in colonization of mice by Citrobacter rodentium. Infect. Immun. 74, 2328-2337 (2006).
48. Mundy R, Pickard D, Wilson RK, Simmons CP, Dougan G, Frankel G: Identification of a novel type IV pilus gene cluster required for gastrointestinal colonization of Citrobacter rodentium. Mol. Microbiol. 48, 795-809 (2003).
49. McNamara BP, Koutsouris A, O'Connell CB, Nougayrede JP, Donnenberg MS, Hecht G: Translocated EspF protein from enteropathogenic Escherichia coli disrupts host intestinal barrier function. J. Clin. Invest. 107, 621-629 (2001).
50. Guttman JA, Li Y, Wickham ME, Deng W, Vogl AW, Finlay BB: Attaching and effacing pathogen-induced tight junction disruption in vivo. Cell. Microbiol. 8, 634-645 (2006).
51. Dean P, Kenny B: Intestinal barrier dysfunction by enteropathogenic Escherichia coli is mediated by two effector molecules and a bacterial surface protein. Mol. Microbiol. 54, 665-675 (2004).
52. Guttman JA, Samji FN, Li Y, Deng W, Lin A, Finlay BB: Aquaporins contribute to diarrhea caused by attaching and effacing bacterial pathogens. Cell. Microbiol. 9, 131-141 (2007).
53. Wei OL, Hilliard A, Kalman D, Sherman M: Mast cells are required for protection from enteric bacterial infection. J. Immunol. (2004) (In Press).
54. Khan MA, Ma C, Knodler LA et al.: Toll-like receptor 4 contributes to colitis development but not to host defense during Citrobacter rodentium infection in mice. Infect. Immun. 74, 2522-2536 (2006).
55. Lebesis SL, Bommarius B, Parkos CA, Sherman MA, Kalman D: TLR signaling mediated by MyD88 is required for a protective innate immune response by neutrophils to Citrobacter rodentium. J. Immunol. 179, 566-577 (2007).
56. Gibson DL, Ma C, Bergstrom KS, Huang JT, Man C, Vallance BA: MyD88 signalling plays a critical role in host defence by controlling pathogen burden and promoting epithelial cell homeostasis during Citrobacter rodentium-induced colitis. Cell. Microbiol. 10, 618-631 (2008).
57. Bry L, Brenner MB: Critical role of T cell-dependent serum antibody, but not the gut-associated lymphoid tissue, for surviving acute mucosal infection with Citrobacter rodentium, an attaching and effacing pathogen. J. Immunol. 172, 433-441 (2004).
58. + T cells in immunity to infection by the attaching and effacing pathogen Citrobacter rodentium. Infect. Immun. 71, 5077-5086 (2003).
59. Nenci A, Becker C, Wullaert A et al.: Epithelial NEMO links innate immunity to chronic intestinal inflammation. Nature 446, 557-561 (2007).
60. Fitzgerald KA, Rowe DC, Golenbock DT: Endotoxin recognition and signal transduction by the TLR4/MD2-complex. Microbes Infect. 6, 1361-1367 (2004).
61. Gibson DL, Ma C, Rosenberger CM et al.: Toll-like receptor 2 plays a critical role in maintaining mucosal integrity during Citrobacter rodentium-induced colitis. Cell. Microbiol. 10, 388-403 (2008).
62. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R: Recognition of commensal microflora by Toll-like receptors is required for intestinal homeostasis. Cell 118, 229-241 (2004).
63. Miao EA, Andersen-Nissen E, Warren SE, Aderem A: TLR5 and Ipaf: dual sensors of bacterial flagellin in the innate immune system. Semin. Immunopathol. 29, 275-288 (2007).
64. Ren T, Zamboni DS, Roy CR, Dietrich WF, Vance RE: Flagellin-deficient Legionella mutants evade caspase-1- and Naip5-mediated macrophage immunity. PLoS Pathog. 2, e18 (2006).
65. Kim YG, Park JH, Shaw MH, Franchi L, Inohara N, Nunez G: The cytosolic sensors Nod1 and Nod2 are critical for bacterial recognition and host defense after exposure to Toll-like receptor ligands. Immunity 28, 246-257 (2008).
66. Brown KL, Cosseau C, Gardy JL, Hancock RE: Complexities of targeting innate immunity to treat infection. Trends Immunol. 28, 260-266 (2007).
67. Kenny B, DeVinney R, Stein M, Reinscheid DJ, Frey FA, Finlay BB: Enteropathogenic E. coli (EPEC) transfers its receptor for intimate adherence into mammalian cells. Cell 91, 511-5120 (1997).
68. Nougayrede JP, Donnenberg MS: Enteropathogenic Escherichia coli EspF is targeted to mitochondria and is required to initiate the mitochondrial death pathway, Cell. Microbiol. 6, 1097-1111 (2004).
69. Elliott SJ, Mellies JL, Robins-Browne RM, Sasakawa C, Kaper JB: EspG, a novel type III system-secreted protein from enteropathogenic Escherichia coli with similarities to VirA of Shigella flexneri. Infect. Immun. 69, 4027-4033 (2001).
70. Tomson FL, Viswanathan VK, Kanack KJ et al.: Enteropathogenic Escherichia coli EspG disrupts microtubules and in conjunction with Orf3 enhances perturbation of the tight junction barrier. Mol. Microbiol. 56, 447-464 (2005).
71. Pull SL, Doherty JM, Mills JC, Gordon JI, Stappenbeck TS: Activated macrophages are an adaptive element of the colonic epithelial progenitor niche necessary for regenerative responses to injury. Proc. Natl Acad. Sci. USA 102, 99-104 (2005).
72. Radtke F, Clevers H: Self-renewal and cancer of the gut: two sides of a coin. Science 307, 1904-1909 (2005).
73. Savidge TC, Shmakov AN, Walker-Smith JA, Phillips AD: Epithelial cell proliferation in childhood enteropathies. Gut 39, 185-193 (1996).
74. Iimura M, Gallo FL, Hase K, Miyamoto Y, Eckmann L, Kagnoff MF: Cathelicidin mediates innate intestinal defense against colonization with epithelial adherent bacterial pathogens. J. Immunol. 174, 4901-4907 (2005).
75. Zheng Y, Valdez PA, Danilenko DM et al.: Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat. Med. 14, 282-289 (2008).
76. Vallance BA, Deng W, De Grado M, Chan C, Jacobson K, Finlay BB: Modulation of inducible nitric oxide synthase expression by the attaching and effacing bacterial pathogen Citrobacter rodentium in infected mice. Infect. Immun. 70, 6424-6435 (2002).
77. Maresca M, Miller D, Quitard S, Dean P, Kenny B: Enteropathogenic Escherichia coli (EPEC) effector-mediated suppression of antimicrobial nitric oxide production in a small intestinal epithelial model system. Cell. Microbiol. 7, 1749-1762 (2005).
78. Martinez-Argudo I, Sands C, Jepson MA: Translocation of enteropathogenic Escherichia coli across an in vitro M cell model is regulated by its type III secretion system. Cell. Microbiol. 9, 1538-1546 (2007).
79. Carbonare CB, Carbonare SB, Carneiro-Sampaio MM: Early acquisition of serum and saliva antibodies reactive to enteropathogenic Escherichia coli virulence-associated proteins by infants living in an endemic area. Pediatr. Allergy Immunol. 14, 222-228 (2003).
80. Martinez MB, Taddei CR, Ruiz-Tagle A, Trabulsi LR, Giron JA: Antibody response of children with enteropathogenic Escherichia coli infection to the bundle-forming pilus and locus of enterocyte effacement-encoded virulence determinants. J. Infect. Dis. 179, 269-274 (1999).
81. Iwasaki A, Kasan BL: Mucosal immunity and inflammation. I. Mucosal dendritic cells: their specialized role in initiating T cell responses. Am. J. Physiol. 276, G1074-G1078 (1999).
82. Chen CC, Louie S, McCormick BA, Walker WA, Shi HN: Helminth-primed dendritic cells alter the host response to enteric bacterial infection. J. Immunol. 176, 472-483 (2006).
83. McGeachy MJ, Bak-Jensen KS, Chen Y et al.: TGF-β and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology. Nat. Immunol. 8, 1390-1397 (2007).
84. Mangan PR, Harrington LE, O'Quinn DB et al.: Transforming growth factor-β induces development of the T(H)-17 lineage. Nature 441, 231-234 (2006).
85. Wei OL, Hilliard A, Kalman D, Sherman M: Mast cells limit systemic bacterial dissemination but not colitis in response to Citrobacter rodentium. Infect. Immun. 3, 1978-1985 (2005).
86. Celli J, Olivier M, Finlay BB: Enteropathogenic Escherichia coli mediates antiphagocytosis through the inhibition of PI 3-kinase-dependent pathways. EMBO J. 20, 1245-1258 (2001).
87. Cox D, Berg JS, Cammer M et al.: Myosin X is a downstream effector of PI(3)K during phagocytosis. Nat. Cell Biol. 4, 469-477 (2002).
88. Iizumi Y, Sagara H, Kabe Y et al.: The enteropathogenic E. coli effector EspB facilitates microvillus effacing and antiphagocytosis by inhibiting myosin function. Cell Host Microbe 2, 383-392 (2007).
89. Marches O, Covarelli V, Dahan S et al.: EspJ of enteropathogenic and enterohaemorrhagic Escherichia coli inhibits opson-phagacytosis. Cell. Microbiol. 10, 1104-1115 (2008).
90. Di Nardo A, Vitiello A, Gallo RL: Cutting edge: mast cell antimicrobial activity is mediated by expression of cathelicidin antimicrobial peptide. J. Immunol. 170, 2274-2278 (2003).
91. Stappenbeck TS, Hooper LV, Gordon JI: Developmental regulation of intestinal angiogenesis by indigenous microbes via Paneth cells. Proc. Natl Acad. Sci. USA 99, 15451-15455 (2002).
92. Hooper LV, Midtvedt T, Gordon JI: How host-microbial interactions shape the nutrient environment of the mammalian intestine. Annu. Rev. Nutr. 22, 283-307 (2002).
93. Servin AL: Antagonistic activities of lactobacilli and bifidobacteria against microbial pathogens. FEMS Microbiol. Rev. 28, 405-440 (2004).
94. Chen CC, Louie S, Shi HN, Walker WA: Preinoculation with the probiotic Lactobacillus acidophilus early in life effectively inhibits murine Citrobacter rodentium colitis. Pediatr. Res. 58, 1185-1191 (2005).
95. Johnson-Henry KC, Nadjafi M, Avitzur Y et al.: Amelioration of the effects of Citrobacter rodentium infection in mice by pretreatment with probictics. J. Infect. Dis. 191, 2106-2117 (2005).
96. Majno G, Palade GE: Studies on inflammation. I. The effect of histamine and serotonin on vascular permeability: an electron microscopic study. J. Biophys. Biochem. Cytol. 11, 571-605 (1961).
97. Malviya R, Abraham SN: Clinical implications of mast cell-bacteria interaction. J. Mol. Med. 76, 617-623 (1998).
98. Sasaki M, Sitaraman SV, Babbin BA et al.: Invasive Escherichia coli are a feature of Crohn's disease. Lab. Invest. 87, 1042-1054 (2007).
99. Fukata M, Michelsen KS, Eri R et al.: Toll-like receptor-4 is required for intestinal response to epithelial injury and limiting bacterial translocation in a murine model of acute colitis. Am. J. A. Physiol. Gastrointest. Liver Physiol. 288, G1055-G1065 (2005).
100. Hancock RE, Sahl HG: Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat. Biotechnol. 24, 1551-1557 (2006).
101. Borenshtein D, Nambiar PR, Groff EB, Fox JG, Schauer DB: Development of fatal colitis in FVB mice infected with Citrobacter rodentium. Infect. Immun. 75, 3271-3281 (2007).